Can Low-Dose Aspirin Cause Gastrointestinal Bleeding?
Yes, low-dose aspirin can definitely cause gastrointestinal bleeding, with studies showing it increases the risk of major GI bleeding by approximately 2 times compared to non-users. 1
Risk of GI Bleeding with Low-Dose Aspirin
Low-dose aspirin (75-325 mg daily) significantly increases the risk of gastrointestinal bleeding through its antiplatelet effects:
- A meta-analysis of 35 randomized controlled trials found that aspirin at doses of 75-325 mg daily increased the hazard ratio for major gastrointestinal bleeding to 1.31 (95% CI 1.21-1.42) 1
- For average-risk individuals without bleeding history or concurrent anticoagulants, this translates to one or two GI bleeding events per 1,000 person-years 1
- The relative risk of upper GI bleeding with low-dose aspirin in a large cohort study was 2.6 (95% CI 2.2-2.9) 2
- Even at the lowest doses (81 mg/day), aspirin can cause endoscopic ulcers in approximately 7% of users within 12 weeks 1
Dose-Response Relationship
The risk of GI bleeding with aspirin demonstrates a clear dose-response relationship:
- Higher doses of aspirin (300-325 mg) carry greater bleeding risk than lower doses (75-162.5 mg) 1
- A prospective cohort study of nearly 33,000 men showed that compared to non-users, the risk of upper GI bleeding increased progressively: 3
- 1.05 for 0.5-1.5 tablets/week
- 1.31 for 2-5 tablets/week
- 1.63 for 6-14 tablets/week
- 2.40 for >14 tablets/week
Risk Factors That Increase Bleeding Risk
Several factors substantially increase the risk of GI bleeding in aspirin users:
- Advanced age (risk increases approximately 4% per year) 1
- History of previous peptic ulcer or GI bleeding (most significant risk factor, with odds ratio up to 13.5) 1
- Concurrent use of:
- Helicobacter pylori infection 5
- Uncontrolled hypertension 1
Timing of Bleeding Risk
The risk of GI bleeding with aspirin is not uniform over time:
- A meta-analysis by Rothwell found that major extracranial bleeding (mainly gastrointestinal) occurred primarily in the short term (<3 years) following initiation of aspirin 1
- After 3 years, low-dose aspirin (<300 mg) was not significantly associated with continued risk of such events 1
Protective Strategies
For patients who require aspirin therapy but are at increased risk for GI bleeding:
- Use the lowest effective dose of aspirin (75-100 mg/day) 4
- Consider co-therapy with a proton pump inhibitor (PPI) for high-risk patients 1
- H. pylori eradication may be beneficial in patients with history of ulcers 5
Important Caveats
- Enteric-coated or buffered aspirin preparations do not reduce the risk of major upper GI bleeding 1
- Discontinuing aspirin after a GI bleeding event may increase mortality - a study showed doubling of all-cause mortality in patients who discontinued aspirin after GI bleeding 6
- The decision to use aspirin should balance cardiovascular benefits against bleeding risks, especially in older adults 1
For patients experiencing GI bleeding while on aspirin, immediate medical attention is required, as indicated by symptoms such as black stools, vomiting blood, or persistent abdominal pain 7.